Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2)

Journal of Tissue Engineering and Regenerative Medicine

Volumn 1, Issue 4, 2007, Pages 306-313

  Maegawa, Naoki ^a,b   Kawamura, Kenji ^a   Hirose, Motohiro ^b   Yajima, Hiroshi ^a   Takakura, Yoshinori ^a   Ohgushi, Hajime ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Bone; Bonemorphogenetic protein 2 (BMP 2); Differentiation; Fibroblast growth factor 2 (FGF 2); Mesenchymal stromal cells; Tissue culture; Tissue engineering

Indexed keywords

ASCORBIC ACID; BONE; CELL ENGINEERING; FIBROBLASTS; FLOWCHARTING; MATRIX ALGEBRA; OSTEOBLASTS; PHOSPHATASES; PHOSPHOLIPIDS; TISSUE ENGINEERING;

BONE MATRIX; BONE MORPHOGENETIC PROTEIN-2; BONEMORPHOGENETIC PROTEIN-2; DIFFERENTIATION; FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STROMAL CELLS; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC MEDIA; TISSUES ENGINEERINGS;

TISSUE CULTURE;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; OSTEOBLAST; RAT; STROMA CELL;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOCALCIN; RATS; RNA, MESSENGER; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 39149089339     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.41     Document Type: Article

References (35)

1. Canalis E, Centrella M, McCarthy T. 1988; Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81: 1572-1577.
2. Caplan AI. 1991; Mesenchymal stem cells. J Orthop Res 9: 641-650.
3. Chaudhari A, Ron E, Rethman MP. 1997; Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Mol Cell Biochem 67: 31-39.
4. Debiais F, Hott M, Graulet AM, Marie PJ. 1998; The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 13: 645-654.
5. Dudley AT, Godin RE, Robertson EJ. 1999; Interaction between FGF and BMP signalling pathways regulates development of metanephric mesenchyme. Genes Dev 13: 1601-1613.
6. Ericson J, Norlin S, Jessell TM, Edlund T. 1998; Integrated FGF and BMP signalling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125: 1005-1015.
7. Fakhry A, Ratisoontorn C, Vedhachalam C, et al. 2005; Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stagedependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36: 254-266.
8. Fujimura K, Bessho K, Okubo Y, et al. 2002; The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch Oral Biol 47: 577-584.
9. Hanada K, Dennis JE, Caplan AL. 1997; Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12: 1606-1614.
10. Hayashi H, Ishisaki A, Suzuki M, Imamura T. 2001; BMP-2 augments FGF induced differentiation of PC12 cells through upregulation of FGF receptor-1 expression. J Cell Sci 114: 1387-1395.
11. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992; Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88.
12. Higashinakagawa M. 1999; Biological effects of basic fibroblast growth factor (bFGF) and osteogenic protein-1 (OP-1/BMP-7) on bone marrow cells and development of cell-hybrid artificial bone. Kokubyo Gakkai Zasshi 66: 118-130 [in Japanese].
13. Hirose M, Kotobuki N, Machida H, Uchimura E, Ohgushi H. 2003; Quantitative monitoring of in vitro mineralization process using fluorescent dyes. Key Eng Mater 240: 715-718.
14. Joost D, De Bruijn JD, van der Brink I, Mendes S, et al. 1999; Bone induction by implants coated with cultured osteogenic bone marrow cells. Adv Dent Res 13: 74-81.
15. Kawate K, Yajima H, Ohgushi H, et al. 2006; Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with β-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30: 960-962.
16. Kim HJ, Bae SC, Choi JY, Ryoo HM. 2003; The protein kinase C pathway plays a central role in the fibroblast growth factorstimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319-326.
17. Li RH, Wozney JM. 2001; Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19: 255-265.
18. Locklin RM, Oreffo ROC, Triffitt JT. 1999; Effects of TGF-β and βFGF on the differentiation of human bone marrow stromal fibroblasts. Cell Biol Int 23: 185-194.
19. Locklin RM, Williamson MC, Beresford JN, Triffitt JT, Owen ME. 1995; In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin Orthop 313: 27-35.
20. Maniatopoulos C, Sodek J, Melcher AH. 1988; Bone formation in vitro by stromal cells obtained from marrow of young adult rats. Cell Tissue Res 254: 317-330.
21. Morishita T, Honoki K, Ohgushi H, et al. 2006; Tissue engineering approach to the treatment of bone tumours: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30: 115-118.
22. Nakamura Y, Wakitani S, Nakayama J, et al. 2003; Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res 18: 1854-1862.
23. Ohgushi H, Caplan AI. 1999; Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 48: 913-927.
24. Ohgushi H, Kotobuki N, Funaoka H, et al. 2005; Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26: 4654-4661.
25. Ohgushi H, Okumura M. 1990; Osteogenic ability of rat and human marrow cells in porous ceramics. Acta Orthop Scand 61: 431-434.
26. Ono I, Tateshina T, Takita H, Kuboki Y. 1996; Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by basic fibroblast growth factor. J Craniofac Surg 7: 418-425.
27. Quarto R, Mastrogiacomo M, Cancedda R, et al. 2001; Repair of large bone defects with the use of autologous bonemarrowstromal cells. N Engl JMed 344: 385-386.
28. Reddi AH, Sullivan NE. 1980; Matrix-induced endochondral bone differentiation: influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 107: 1291-1299.
29. Saito N, Okada T, Horiuchi H, et al. 2001; A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 19: 332-335.
30. Takita H, Tsuruga E, Ono I, Kuboki Y. 1997; Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur J Oral Sci 105: 588-592.
31. Tsutsumi S, Shimazu A, Miyazaki K, et al. 2001; Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288: 413-419.
32. Uchimura E, Machida H, Kotobuki N, et al. 2003; In situ visualization and quantification of mineralization of cultured osteogenetic cells. Calcif Tissue Int 73: 575-583.
33. Xiao G, Jiang D, Thomas P, et al. 2000; MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275: 4453-4459.
34. Yoshikawa T, Ohgushi H, Tamai S. 1996; Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mat Res 32: 481-492.
35. Zhou YX, Xu X, Chen L, Brodie SG, Deng CX. 2000; A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa 1 and premature fusion of calvarial sutures. Hum Mol Genet 9: 2001-2008.